Odense M, Denmark

Elisabeth Christiansen


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Elisabeth Christiansen: Innovator in Metabolic Disease Treatments

Introduction

Elisabeth Christiansen is a notable inventor based in Odense M, Denmark. She holds two patents in the field of metabolic diseases, contributing to advancements in medical treatments that target critical health issues. Her work focuses on compounds that have the potential to significantly improve the management of conditions such as type II diabetes and hypertension.

Latest Patents

Christiansen's latest patents include the development of novel fluoro-substituted compounds aimed at modulating the G-protein-coupled receptor GPR40. The first patent outlines these compounds' potential in controlling insulin levels in vivo and providing treatment methods for diseases like type II diabetes, ketoacidosis, obesity, and related disorders marked by abnormal plasma lipoproteins and glucose levels. Additionally, her second patent also revolves around compounds that modulate GPR40, reinforcing her commitment to innovating treatments for metabolic diseases.

Career Highlights

Elisabeth Christiansen has had an impactful career, with key positions at respected institutions such as Syddansk Universitet and Caldan Therapeutics Limited. Her educational and research background has provided her with a robust platform to advance her innovative solutions in the medical field, positioning her as a vital contributor to healthcare advancements.

Collaborations

Throughout her career, Christiansen has collaborated with esteemed professionals, including her coworker Trond Ulven, combining expertise to foster development in her patent endeavors. These collaborations have enabled her to strengthen her research and expand the possibilities of her innovations in treating metabolic diseases.

Conclusion

Elisabeth Christiansen exemplifies the spirit of innovation in the medical field, particularly concerning metabolic diseases. With her two patents focusing on GPR40-modulating compounds, she is paving the way for new treatment avenues that could enhance the quality of life for many individuals suffering from metabolic disorders. Her work is a testament to the power of innovation driven by dedicated inventors in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…